Pharmaceutical Research

, Volume 29, Issue 12, pp 3235–3250

Inhibition of Cholesterol Absorption: Targeting the Intestine

Authors

    • Faculty of Pharmaceutical SciencesUniversity of British Columbia
  • Pavel Gershkovich
    • Faculty of Pharmaceutical SciencesUniversity of British Columbia
    • School of PharmacyUniversity of Nottingham
  • Jerald W. Darlington
    • AMCOL International Corporation
  • Kishor M. Wasan
    • Faculty of Pharmaceutical SciencesUniversity of British Columbia
Expert Review

DOI: 10.1007/s11095-012-0858-6

Cite this article as:
Lee, S.D., Gershkovich, P., Darlington, J.W. et al. Pharm Res (2012) 29: 3235. doi:10.1007/s11095-012-0858-6

ABSTRACT

Atherosclerosis, the gradual formation of a lipid-rich plaque in the arterial wall is the primary cause of Coronary Artery Disease (CAD), the leading cause of mortality worldwide. Hypercholesterolemia, elevated circulating cholesterol, was identified as a key risk factor for CAD in epidemiological studies. Since the approval of Mevacor in 1987, the primary therapeutic intervention for hypercholesterolemia has been statins, drugs that inhibit the biosynthesis of cholesterol. With improved understanding of the risks associated with elevated cholesterol levels, health agencies are recommending reductions in cholesterol that are not achievable in every patient with statins alone, underlying the need for improved combination therapies. The whole body cholesterol pool is derived from two sources, biosynthesis and diet. Although statins are effective at reducing the biosynthesis of cholesterol, they do not inhibit the absorption of cholesterol, making this an attractive target for adjunct therapies. This report summarizes the efforts to target the gastrointestinal absorption of cholesterol, with emphasis on specifically targeting the gastrointestinal tract to avoid the off-target effects sometimes associated with systemic exposure.

Key words

absorption atherosclerosis cholesterol heart disease targeted therapy

ABBREVIATIONS

ABC

ATP-binding cassette

ACAT

Acyl CoA cholesterol Acyl transferase

Apo

apolipoprotein

ASO

antisense oligonucleotides

BAS

bile acid sequestrants

CAD

coronary artery disease

LDL

low-density lipoproteins

LXR

liver X receptor

MTP

microsomal triglyceride transfer protein

NPC1L1

Niemann Pick C 1 Like 1

NSAS

nanostructured aluminosilicate

RNAi

RNA interference

SREBP

sterol regulatory element binding protein

Copyright information

© Springer Science+Business Media, LLC 2012